Back to trial details

Intake questionnaire

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Applying to MD Anderson Cancer Center · Houston, Texas

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Autoimmune Disorders?
3. Are you able to travel to Houston for study visits?